Skip to main content
Premium Trial:

Request an Annual Quote

Stacy Williams, David Warden, Molly Holman

Stacy Williams has been named director of the Georgia Center of Innovation-Life Sciences, the state’s Centers of Innovation program said last week.
Williams founded the children’s science toy company Dr. DaBrain Science Toys. She has also served as a scientific advisor at Woodcock Washburn; a partner at an undisclosed Atlanta patent analytics firm; and a science consultant at Prentice Hall.
She holds a PhD in chemistry from Carnegie Mellon University.
The Center of Innovation-Life Sciences is housed on the campus of the Medical College of Georgia in Augusta and provides statewide industry expertise to accelerate the growth of Georgia’s life sciences and biotechnology industries.

InNexus Biotechnology this week said that it has named David Warden to its board of directors.
Warden was a founding partner of Yetter, Warden & Coleman. He holds a JD from the University of Virginia, and an MS and BS in engineering from Purdue University.
InNexus said that adding Warden to its board is part of a strategy to enhance and fortify its intellectual property position supporting the commercialization of monoclonal antibodies based on its Dynamic Cross Linking technology.

Metabasis Therapeutics said this week that Molly Holman has joined the company as vice president of intellectual property.
Holman comes to Metabasis from Almylin Pharmaceuticals, where she was most recently executive director of intellectual property. Prior to this, she practiced patent law at Christie, Parker & Hale and Fish & Richardson, and was a licensing assistant at the Dana Farber Cancer Institute.
Holman received a BS in biology from the University of California at Riverside, a PhD in biology from the University of California at Irvine, and a JD from the University of California at Los Angeles School of Law.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.